Companies are facing technical and marketing pros and cons as they increasingly turn to cold-press CBD extraction as a way around novel food market limitations in the UK and Ireland
CBD is already working from a higher base than many consumer products on the market. But that does not mean there is nothing else to be done
Kanabo, the company behind the UK’s first medicinal cannabis vape, has launched an e-commerce platform to sell its VapePod products to wellness CBD consumers
British American Tobacco (BAT) has invested a further CAD6.3m (USD5.03m) in the Canadian cannabis company Organigram, thereby increasing its stake from 18.8% to 19.5%
The Canadian government is proposing changes to make it easier to conduct non-therapeutic cannabis research in the country and to foster more investigation into the development of cannabis products
Regulatory changes in Israel have enabled a cannabis company to advance breeding methods and grow plants that promise to yield higher levels of cannabinoids
Scientists around the world are starting to look even further afield for potential uses of cannabis in medical applications, such as treating the symptoms of long Covid-19, Alzheimer’s-related agitation, and to alleviate the pain resulting from HIV
US firm 22nd Century Group plans to use its expertise in plant science, biotechnology and genetics to move further into cannabinoid production
The latest offering from the company that first devised the Juul e-cigarette looks sure to be a new Californian craze – a new vaping pod “made solely from pure cannabis”
Potential demand for rarer cannabinoids is prompting firms to explore other methods of manufacturing, such as biosynthesis and chemical synthesis, to give higher yields at lower cost
Cannabis firms continued to expand their footprint through to the end of 2021, with the lucrative US market being the strategic focus of many acquisitions, covering retail chains and tech companies
The UK’s National Health Service (NHS) has expressed some interest in the viability of psychedelics as a course of treatment
Interest in psychedelic drugs and treatments continues to grow, as evidenced by three major takeovers in Canada and the USA, two involving drug treatments developments and another offering a network of ketamine infusion treatment centres
A plan to solve issues with cannabis e-commerce has attracted investors to the tune of around $130m in total
NFL veteran Chris Hetherington has launched a CBD oil derived entirely from orange peel, describing it as “crystalline CBD at a purity and consistency difficult to match with cannabis or hemp-derived material”
New methods for laboratory production of cannabinoids show some promise – but it’s still not clear whether they will yield enough to be commercially viable
London-listed Kanabo has launched the first medical cannabis vaping product in the UK in a move the company’s founder hopes will ultimately revolutionise the way medicines are administered
CBD and cannabis startups from Scotland to Florida are attracting increasing numbers of investors as they scale up their businesses and break crowd-funding records in the process
UK venture capital fund Neo Kuma has invested £5m across seven healthcare companies focused on the use of psychedelics to help combat mental health issues
Tim Phillips, CBD-Intel’s managing director, recently presented at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 28th April 2021. In addition to an overview of the impact of Covid-19 on the retail environment, he provided a comparative analysis of the current Novel Food legislation in the UK and the US, as well as discussion around how » Continue Reading.
This chart shows the origins of some select minor cannabinoids that CBD-Intel covered in a recent business briefing. It provides a brief review of some of cannabis’s lesser-known compounds – the so-called “minor cannabinoids” – with an emphasis on their potential applications. Arising from other precursors, cannabigerolic acid (CBGA) – the so-called “mother cannabinoid” – is metabolised into cannabichromenic acid (CBCA), cannabidiolic acid (CBDA), » Continue Reading.
Australian medicinal cannabis firm Cann has moved quickly to maximise the benefits of its CBD Gelpell capsule technology by entering into a collaboration deal with healthcare technology firm Emyria
While legal cannabis is still a relatively new industry, investors are already looking for the next sector to boom – and many think that will be psychedelics
The newest cannabinoid craze is stirring up controversy in the emerging legal hemp industry. Delta-8 THC, produced from hemp-extracted CBD, promises a legal high – but, many wonder, at what cost?
The Home Office has not changed licensing requirements for importers of CBD into the UK. The minister for policing, Christopher “Kit” Malthouse, has requested an updated recommendation from the Advisory Council on the Misuse of Drugs (ACMD) on acceptable THC levels in CBD consumer products. The ACMD has not yet responded and the previous limit of 1 mg generic tolerance for » Continue Reading.
The European Food Safety Authority (EFSA) has stated that it is in contact with other similar agencies such as the Food Standards Agency (FSA) in the UK, but only specified that it would not treat applications that had been approved in other jurisdictions any differently during its own assessment process. But beyond that, it has not stated what other influence the FSA » Continue Reading.
The Portman Group’s first decision on a complaint regarding a CBD product has gone largely unreported but could have a very significant impact on that part of the market. The voluntary alcohol industry regulator has said it is bringing out further guidance for producers of CBD alcoholic beverages – the first time it will have addressed the issue. So it is important to » Continue Reading.
The decision – which should be noted is still only preliminary, though almost certainly to be confirmed with subsequent updating of the cosmetics ingredients (CosIng) database – should allow a wider range of cosmetic products onto the market. Exactly how much of an impact the change – when it eventually is confirmed – will make in reality largely depends on » Continue Reading.
The top-line answer is that it is wholly neither. There are elements of both in any position taken on the news. BAT’s entrance into the market with its vaping product under the Vuse brand (coming in three flavours – mint, mango and berry – and two strengths – 50 mg at £9.99 and 100 mg at £14.99) would be priced at the higher end of » Continue Reading.
Big Tobacco has entered the CBD sector with British American Tobacco (BAT) launching a CBD e-liquid cartridge compatible with its Vuse vaping device
Californian “cellular agriculture company” Cellibre has closed a round of funding that will enable it to accelerate the production of pharmaceutical-grade cannabinoids via fermentation
Overall it seems the industry – particularly in Europe – is not expecting much from Black Friday sales. European companies appear to consider CBD products more as health products that are requirement purchases throughout the year as opposed to lifestyle products that might be purchased as a one off during a special sales event. The situation may be slightly different in the US where Black Friday – » Continue Reading.
How important is the CJEU decision on the Kanavape case? The judgement in favour of CBD from the Courts of Justice of the European Union (CJEU) will almost certainly have significant long-term consequences for the CBD industry in Europe. It will likely influence the European Commission (EC)’s further assessment of the question of whether CBD is a narcotic. The preliminary opinion » Continue Reading.
Berta Camps Bisbal, CBD-Intel’s senior legal analyst, presented a comparative analysis of state laws in the US at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 18th November. She presented an overview of the federal farm bill as well as CBD at the federal level versus state level. You can now watch her presentation to obtain » Continue Reading.
Current lack of success in Canada and unsupportive regulations in the US have not stopped cannabinoid companies from exploring the beverages sector
CBD, generally seen as a health or wellness product, and “bad guy” nicotine are almost opposites in terms of public perception – but could putting the two together make commercial sense?
There are still quite a few unanswered questions regarding the novel food application process under the FSA. Fortunately the requirement of having toxicological data
Although still illegal in the US and Canada, psychedelic substances such as fungus-derived psilocybin are becoming increasingly acceptable, research suggests
Commercial interest in mushrooms as active ingredients is on the rise – despite legal issues that severely curtail commercial opportunities
Maria Alejandra Estanga, our market analysts, presented the current status of the topicals market across the most important CBD markets during the Virtual Cannacosmo Health + Beauty Expo on 29st September.
US-based CBD producer Folium Biosciences is looking to tap Asian markets by creating a dedicated stalk extraction line which it believes will meet the strict regulatory requirements of Japan and South Korea
The Association for the Cannabinoid Industry (ACI) will move forward with its consortium approach to obtaining toxicology and safety data for CBD with at least 15 companies having signed up and an undisclosed number still in discussion
2020 seems an unlikely year for the emergence of any new industry, yet this is exactly what has happened in Hong Kong, where there are now locally produced CBD food and drink products
Britain’s newfound enthusiasm for CBD products has joined with the passion for alcohol, with some companies are aiming to capitalise on the trend for “drinking less but drinking better” by launching CBD spirits, especially gin
Studies looking at the potential for CBD to treat or alleviate COVID-19 symptoms continue to progress – with one study hinting at promising results combining CBD with other terpene products
Nanotechnology – referring to any kind of technology dealing in very small scales such as atomic, molecular or supramolecular – could improve some of the disadvantages of cannabinoids, such as solubility
Scientists are increasingly starting to study how differing methods of consumption can affect CBD bioavailability – the ability to enter your bloodstream and induce effects
Maria Alejandra Estanga, one of CBD-Intel’s market analysts, presented the latest CBD market trends & country comparison at the CBD live during VOXPO – Virtual Online Vape & CBD Expo on 31st July.
Current indications are that the EC is leaning heavily towards the idea that CBD does indeed count as a narcotic under the 1961 Un Convention.
A new line of sparkling CBD drinks is to be launched in the Colorado market in what may be an indication of how high-profile companies approach the CBD market during its continued period of uncertainty